Cancer research, conducted through the Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai, strives to translate research discoveries into safe, effective therapies. The institute supports basic and clinical research in many cancer-related areas, including blood cell development, gene cloning, bioactive extracellular vesicles (oncosomes) profiling and stem cells. Cedars-Sinai researchers are seeking more effective ways to diagnose, treat and prevent many forms of cancer.
Key areas of research include cancer biology, population science, and experimental therapies.
Accelerating clinical translation of basic science discoveries from bench to bedside to improve the clinical outcome of patients with prostate, kidney, and bladder cancers.